Optimizing drug discovery in a fast-moving market

  • In 2021, over 200 biopharma executives were surveyed about changing approaches to building biologic drug development pipelines.
  • Organizations are now considering different approaches, focusing on where and how they conduct their development programs.
  • This executive summary presents the findings from this outreach.

Request Free!

Optimizing drug discovery in a fast-moving market

  • In 2021, over 200 biopharma executives were surveyed about changing approaches to building biologic drug development pipelines.
  • Organizations are now considering different approaches, focusing on where and how they conduct their development programs.
  • This executive summary presents the findings from this outreach.

Request Free!